{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:29:15Z","timestamp":1793316555091,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-05594-9","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T05:07:04Z","timestamp":1743052024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparative efficacy and safety of etanercept and adalimumab in the treatment of polyarticular juvenile idiopathic arthritis"],"prefix":"10.1186","volume":"25","author":[{"given":"Lanlan","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"issue":"9783","key":"5594_CR1","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","volume":"377","author":"B Prakken","year":"2011","unstructured":"Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377(9783):2138\u201349.","journal-title":"Lancet"},{"issue":"1","key":"5594_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41572-021-00332-8","volume":"8","author":"A Martini","year":"2022","unstructured":"Martini A, Lovell DJ, Albani S, et al. Juvenile idiopathic arthritis. Nat Reviews Disease Primers. 2022;8(1):5.","journal-title":"Nat Reviews Disease Primers"},{"issue":"7","key":"5594_CR3","doi-asserted-by":"publisher","first-page":"103337","DOI":"10.1016\/j.autrev.2023.103337","volume":"22","author":"N Bansal","year":"2023","unstructured":"Bansal N, Pasricha C, Kumari P, et al. A comprehensive overview of juvenile idiopathic arthritis: from pathophysiology to management. Autoimmun Rev. 2023;22(7):103337.","journal-title":"Autoimmun Rev"},{"key":"5594_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12969-021-00629-8","volume":"19","author":"LN Zaripova","year":"2021","unstructured":"Zaripova LN, Midgley A, Christmas SE, et al. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. Pediatr Rheumatol. 2021;19:1\u201314.","journal-title":"Pediatr Rheumatol"},{"issue":"4","key":"5594_CR5","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1093\/rheumatology\/kez291","volume":"59","author":"M-M Gr\u00f6nlund","year":"2020","unstructured":"Gr\u00f6nlund M-M, Remes-Pakarinen T, Kr\u00f6ger L, et al. Efficacy and safety of Tocilizumab in a real-life observational cohort of patients with polyarticular juvenile idiopathic arthritis. Rheumatology. 2020;59(4):732\u201341.","journal-title":"Rheumatology"},{"issue":"11","key":"5594_CR6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrrheum.2009.209","volume":"5","author":"C Macaubas","year":"2009","unstructured":"Macaubas C, Nguyen K, Milojevic D, et al. Oligoarticular and polyarticular JIA: epidemiology and pathogenesis. Nat Rev Rheumatol. 2009;5(11):616\u201326.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"5594_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rdc.2021.07.009","volume":"47","author":"K Onel","year":"2021","unstructured":"Onel K, Rumsey DG, Shenoi S. Juvenile idiopathic arthritis treatment updates. Rheumatic Disease Clin. 2021;47(4):545\u201363.","journal-title":"Rheumatic Disease Clin"},{"issue":"13","key":"5594_CR8","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.3390\/ijerph19137793","volume":"19","author":"AR Azab","year":"2022","unstructured":"Azab AR, Kamel FH, Basha MA, et al. Impact of clinical pilates exercise on pain, cardiorespiratory fitness, functional ability, and quality of life in children with polyarticular juvenile idiopathic arthritis. Int J Environ Res Public Health. 2022;19(13):7793.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"5594_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s00393-021-01114-z","volume":"81","author":"J-P Haas","year":"2022","unstructured":"Haas J-P, Weimann V, Feist E. Polyartikul\u00e4re juvenile idiopathische arthritis und rheumatoide arthritis. Z F\u00fcr Rheumatologie. 2022;81(1):4\u201313.","journal-title":"Z F\u00fcr Rheumatologie"},{"issue":"5","key":"5594_CR10","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/pde.13859","volume":"36","author":"D Groth","year":"2019","unstructured":"Groth D, Perez M, Treat JR, et al. Tumor necrosis factor-\u03b1 inhibitor\u2010induced psoriasis in juvenile idiopathic arthritis patients. Pediatr Dermatol. 2019;36(5):613\u20137.","journal-title":"Pediatr Dermatol"},{"issue":"13","key":"5594_CR11","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMoa2022516","volume":"384","author":"IB McInnes","year":"2021","unstructured":"McInnes IB, Anderson JK, Magrey M, et al. Trial of Upadacitinib and adalimumab for psoriatic arthritis. N Engl J Med. 2021;384(13):1227\u201339.","journal-title":"N Engl J Med"},{"issue":"18","key":"5594_CR12","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1093\/cercor\/bhad266","volume":"33","author":"R Rizzi","year":"2023","unstructured":"Rizzi R, Bidelman GM. Duplex perception reveals brainstem auditory representations are modulated by listeners\u2019 ongoing percept for speech. Cereb Cortex. 2023;33(18):10076\u201386.","journal-title":"Cereb Cortex"},{"issue":"2","key":"5594_CR13","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rhuematol. 2004;31(2):390\u20132.","journal-title":"J Rhuematol"},{"issue":"12","key":"5594_CR14","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s12098-022-04414-7","volume":"90","author":"F Remthangpuii","year":"2023","unstructured":"Remthangpuii F, Maheshwari A, Gulati S, et al. Serum calprotectin levels in different subtypes of juvenile idiopathic arthritis (JIA) and its correlation with quantitative CRP and JADAS-27. Indian J Pediatr. 2023;90(12):1177\u201381.","journal-title":"Indian J Pediatr"},{"issue":"6","key":"5594_CR15","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s00431-024-05538-y","volume":"183","author":"MC Polat","year":"2024","unstructured":"Polat MC, \u00c7elikel E, Tekin ZE, et al. When should the use Ofbiological agents be considered in persistent oligoarticular juvenile idiopathicarthritis patients? Eur J Pediatr. 2024;183(6):2725\u201331.","journal-title":"Eur J Pediatr"},{"issue":"7","key":"5594_CR16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1136\/annrheumdis-2019-216843","volume":"79","author":"A Klein","year":"2020","unstructured":"Klein A, Minden K, Hospach A, et al. Treat-to-target study for improved outcome in polyarticular juvenile idiopathic arthritis. Ann Rheum Dis. 2020;79(7):969\u201374.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5594_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12969-022-00676-9","volume":"20","author":"WD Soulsby","year":"2022","unstructured":"Soulsby WD, Balmuri N, Cooley V, et al. Social determinants of health influence disease activity and functional disability in polyarticular juvenile idiopathic arthritis. Pediatr Rheumatol. 2022;20(1):18.","journal-title":"Pediatr Rheumatol"},{"key":"5594_CR18","doi-asserted-by":"crossref","unstructured":"Huang Z, Lee PY, Yao X et al. Tofacitinib treatment of refractory systemic juvenile idiopathic arthritis. Pediatrics, 2019;143(5).","DOI":"10.1542\/peds.2018-2845"},{"key":"5594_CR19","doi-asserted-by":"publisher","first-page":"1400036","DOI":"10.3389\/fimmu.2024.1400036","volume":"15","author":"BW Hounkpe","year":"2024","unstructured":"Hounkpe BW, Sales LP, Ribeiro SC, et al. Transcriptomic signatures of classical monocytes reveal pro-inflammatory modules and heterogeneity in polyarticular juvenile idiopathic arthritis. Front Immunol. 2024;15:1400036.","journal-title":"Front Immunol"},{"key":"5594_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-physiol-021119-034440","volume":"82","author":"CM Gendron","year":"2020","unstructured":"Gendron CM, Chakraborty TS, Chung BY, et al. Neuronal mechanisms that drive organismal aging through the lens of perception. Annu Rev Physiol. 2020;82:227\u201349.","journal-title":"Annu Rev Physiol"},{"issue":"1","key":"5594_CR21","first-page":"135","volume":"19","author":"LN Zaripova","year":"2021","unstructured":"Zaripova LN, Midgley A, Christmas SE, et al. Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches. pediatr rheumatol. Online J. 2021;19(1):135.","journal-title":"Online J"},{"key":"5594_CR22","doi-asserted-by":"crossref","unstructured":"Onel K, Rumsey DG, Shenoi S. Juvenile Idiopathic Arthritis Treat Updates Rheum Dis Clin North Am. 2021;47(4):545\u201363.","DOI":"10.1016\/j.rdc.2021.07.009"},{"issue":"12","key":"5594_CR23","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41584-023-01042-z","volume":"19","author":"CH Hinze","year":"2023","unstructured":"Hinze CH, Foell D, Kessel C. Treatment of systemic juvenile idiopathicarthritis. Nat Rev Rheumatol. 2023;19(12):778\u201389.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"5594_CR24","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.3390\/biomedicines10102401","volume":"10","author":"L Caputi","year":"2022","unstructured":"Caputi L, Boncoraglio GB, Bernardi G, et al. Anti-cyclic citrullinated peptide antibody index in the cerebrospinal fluid for the diagnosis and monitoring of rheumatoid meningitis. Biomedicines. 2022;10(10):2401.","journal-title":"Biomedicines"},{"key":"5594_CR25","doi-asserted-by":"crossref","unstructured":"Feger DM, Longson N, Dodanwala H et al. Comparison of adults with polyarticular juvenile idiopathic arthritis to adults with rheumatoid arthritis: a cross-sectional analysis of clinical features and medication use. JCR: Journal of Clinical Rheumatology, 2019;25(4):163\u2013170.","DOI":"10.1097\/RHU.0000000000000819"},{"issue":"6","key":"5594_CR26","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3899\/jrheum.211039","volume":"49","author":"A Marino","year":"2022","unstructured":"Marino A, Orsini F, Pregnolato F, et al. Tumor necrosis factor-\u03b1 Inhibition before and after rituximab treatment in juvenile idiopathic arthritis: what shall we expect? A pilot study. J Rhuematol. 2022;49(6):654\u20136.","journal-title":"J Rhuematol"},{"key":"5594_CR27","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s100670200012","volume":"21","author":"L-S Ou","year":"2002","unstructured":"Ou L-S, See L-C, Wu C-J, et al. Association between serum inflammatory cytokines and disease activity in juvenile idiopathic arthritis. Clin Rheumatol. 2002;21:52\u20136.","journal-title":"Clin Rheumatol"},{"key":"5594_CR28","unstructured":"Ling JJ. Clinical analysis of polyarticular juvenile idiopathic arthritis and non-traditional treatment of mid-long term follow-up observation.[D]. Huazhong University of Science and Technology, 2019."},{"key":"5594_CR29","unstructured":"Chen JJ..,Clinical analysis of 156 cases of polyarticular juvenile idiopathic arthritis[. D].Chongqing Medical University, 2019."},{"issue":"1","key":"5594_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s40744-023-00628-z","volume":"11","author":"MM Simonds","year":"2024","unstructured":"Simonds MM, Freer ST, Al-Jaberi L, et al. Adalimumab effectively decreases inflammation downstream of TNF\u03b1 signaling in synoviocytes from extended oligoarticular juvenile idiopathic arthritis. Rheumatol Therapy. 2024;11(1):143\u201355.","journal-title":"Rheumatol Therapy"},{"key":"5594_CR31","first-page":"45","volume":"26","author":"XH Liu","year":"2014","unstructured":"Liu XH, Zou Z, Cai SF, et al. To investigate the clinical efficacy and safety of etanercept in the treatment of polyarticular juvenile idiopathic arthritis. Contemp Med. 2014;26:45\u20136.","journal-title":"Contemp Med"},{"issue":"1","key":"5594_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12969-022-00763-x","volume":"20","author":"JW van Straalen","year":"2022","unstructured":"van Straalen JW, de Roock S, Giancane G, et al. Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis: a propensity score matched cohort study. Pediatr Rheumatol. 2022;20(1):96.","journal-title":"Pediatr Rheumatol"},{"key":"5594_CR33","doi-asserted-by":"crossref","unstructured":"Brunner HI, Nanda K, Toth M, et al. Safety and effectiveness of adalimumab in patients with polyarticular course of juvenile idiopathic arthritis: STRIVE registry Seven-Year interim results. Volume 72. Arthritis Care & Research, 2020;1420\u201330. 10.","DOI":"10.1002\/acr.24044"},{"issue":"2","key":"5594_CR34","doi-asserted-by":"publisher","first-page":"e001208","DOI":"10.1136\/rmdopen-2020-001208","volume":"6","author":"DJ Lovell","year":"2020","unstructured":"Lovell DJ, Brunner HI, Reiff AO, et al. Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate. RMD Open. 2020;6(2):e001208.","journal-title":"RMD Open"}],"updated-by":[{"DOI":"10.1186\/s12887-026-06852-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000}}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05594-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05594-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05594-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:13:33Z","timestamp":1777875213000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-025-05594-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5594"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05594-9","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12887-026-06852-0","URL":"https:\/\/doi.org\/10.1186\/s12887-026-06852-0","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of Children\u2019s Hospital of Hebei Province(NO.2022-143B), and the study was performed in accordance with the Helsinki II declaration. Signed informed consent from all participants or their guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}